QuickView for PDE4D;jsessionid=0F4ED5A3404A8DBC6D273D4A274739C6;jsessionid=14D59171A7A54167D31D5AF03DFBD7F9;jsessionid=BC0B543C1FF956BB017B1694B31A6192 (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Extraocular muscle
Skeletal muscle
Jejunum
T Lymphocyte (CD8+) of peripheral blood
Saphenous vein

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Cerebrovascular disease
Abscess
Hutchinson-Gilford syndrome
Bronchitis
Antiphospholipid syndrome

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

4-hydroxyestradiol-17 beta
Luteinizing Hormone
BCL9 protein, human
Poliovirus Vaccines
BRL 37344

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

LEF1
NCSTN
FUBP3
ZFP90
TCTN1

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

ZORYVETM (Roflumilast) Cream: A Topical Phosphodiesterase-4 Inhibitor for the Treatment of Psoriasis…
PDE4D mediates impaired β-adrenergic receptor signalling in the sinoatrial node in mice with hyperte…
Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhi…
Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19.
Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF…

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for PDE4D;jsessionid=0F4ED5A3404A8DBC6D273D4A274739C6;jsessionid=14D59171A7A54167D31D5AF03DFBD7F9;jsessionid=BC0B543C1FF956BB017B1694B31A6192

Explore Clinical Trials Results